CoChat

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission

Open access
Corces-Zimmerman, M. Ryan, Hong, Wan-Jen, Weissman, Irving L., Medeiros, Bruno C., Majeti, Ravindra · 2014 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Cancer is widely characterized by the sequential acquisition of genetic lesions in a single lineage of cells. Our previous studies have shown that, in acute myeloid leukemia (AML), mutation acquisition occurs in functionally normal hematopoietic stem cells (HSCs). These preleukemic HSCs harbor some, but not all, of the mutations found in the leukemic cells. We report here the identification of patterns of mutation acquisition in human AML. Our findings support a model in which mutations in "landscaping" genes, involved in global chromatin changes such as DNA methylation, histone modification, and chromatin looping, occur early in the evolution of AML, whereas mutations in "proliferative" genes occur late. Additionally, we analyze the persistence of preleukemic mutations in patients in remission and find CD34+ progenitor cells and various mature cells that harbor preleukemic mutations. These findings indicate that preleukemic HSCs can survive induction chemotherapy, identifying these cells as a reservoir for the reevolution of relapsed disease. Finally, through the study of several cases of relapsed AML, we demonstrate various evolutionary patterns for the generation of relapsed disease and show that some of these patterns are consistent with involvement of preleukemic HSCs. These findings provide key insights into the monitoring of minimal residual disease and the identification of therapeutic targets in human AML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1324297111

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 803

Metadata

Authors
Corces-Zimmerman, M. R., Hong, W.-J., Weissman, I. L., Medeiros, B. C., & Majeti, R.
Affiliations
  • Program in Cancer Biology, Ludwig Center, Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and
  • Institute for Stem Cell Biology and Regenerative Medicine (IN)
  • Stanford Medicine (US)
Venue
Proceedings of the National Academy of Sciences
Published
2014-02-03
Volume
111
Issue
7
Pages
2548-2553
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2148965443
Cited by
705
References
27
Citations by year
2026: 22 · 2025: 18 · 2024: 31 · 2023: 41 · 2022: 44 · 2021: 55 · 2020: 59 · 2019: 91 · 2018: 66 · 2017: 86 · 2016: 80 · 2015: 70 · 2014: 40
FWCI
65.23
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation
  • Burroughs Wellcome Fund
  • California Institute of Regenerative Medicine (TG2-01159)
  • National Institutes of Health (TG2-01159)
  • National Heart, Lung, and Blood Institute (U01HL099995, U01HL099999)
  • National Cancer Institute (F31CA180659, R01CA188055, R01CA086065, T32CA009287, R01CA086017)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
acute myeloid leukemia, hematopoietic stem cells, clonal evolution, epigenetic regulators, DNA methylation, histone modifications, chromatin looping, relapse, minimal residual disease, CD34+ cells, chemoresistance
MeSH terms
Base Sequence, Flow Cytometry, Genotype, Hematopoietic Stem Cells, Humans, Models, Biological, Molecular Sequence Data, Mutation, Preleukemia, Leukemia, Myeloid, Acute, Sequence Analysis, DNA, Antigens, CD34, Epigenesis, Genetic, Exome, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. https://app.cochat.ai/papers/10.1073/pnas.1324297111
The paper
Corces-Zimmerman, M. R., Hong, W.-J., Weissman, I. L., Medeiros, B. C., & Majeti, R. (2014). Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1324297111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.